drugset / Trial / NCT03721874

Effects of 2 Weeks Treatment With Dapagliflozin in Subjects With an Impaired Glucose Homeostasis on Nocturnal Substrate Oxidation

NCT03721874

Phase 4 Completed 16 enrolled Maastricht University AstraZeneca · collab
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study is to investigate the effect of 2 weeks dapagliflozin treatment in individuals with a disrupted glucose homeostasis on the switch between carbohydrate and lipid oxidation during the night

Timeline

Start
2019-04-30
Primary completion
2021-06-29
Completion
2021-06-29

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dapagliflozin Small molecule 10 mg

Indications